Forte Biosciences Inc. (NASDAQ: FBRX)
$20.5700
-0.2000 ( -0.15% ) 22.8K
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Market Data
Open
$20.5700
Previous close
$20.7700
Volume
22.8K
Market cap
$126.27M
Day range
$19.3000 - $22.8700
52 week range
$4.1100 - $28.6800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 124 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Nov 22, 2024 |
| 8-k | 8K-related | 18 | Nov 20, 2024 |
| 8-k | 8K-related | 15 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 58 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Oct 02, 2024 |
| 4 | Insider transactions | 1 | Oct 02, 2024 |
| 8-k | 8K-related | 13 | Sep 20, 2024 |
| 3 | Insider transactions | 2 | Sep 19, 2024 |
| 4 | Insider transactions | 1 | Sep 19, 2024 |